Related references
Note: Only part of the references are listed.Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean Adults
Said A. Jongo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2021)
Scientists hail historic malaria vaccine approval — but point to challenges ahead
Amy Maxmen
NATURE (2021)
Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial
Zita Sulyok et al.
NATURE COMMUNICATIONS (2021)
Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity
Agnes Mwakingwe-Omari et al.
NATURE (2021)
PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection
Sean C. Murphy et al.
PLOS PATHOGENS (2021)
Chemoprophylaxis Vaccination: Phase I Study to Explore Stage-specific Immunity to Plasmodium falciparum in US Adults
Sara A. Healy et al.
CLINICAL INFECTIOUS DISEASES (2020)
Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults
Said A. Jongo et al.
CLINICAL INFECTIOUS DISEASES (2020)
Malaria vaccines since 2000: progress, priorities, products
Patrick E. Duffy et al.
NPJ VACCINES (2020)
Low-Avidity CD4+ T Cell Responses to SARS-CoV-2 in Unexposed Individuals and Humans with Severe COVID-19
Petra Bacher et al.
IMMUNITY (2020)
Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study
Alexandra B. Hogan et al.
PLOS MEDICINE (2020)
A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1
Meta Roestenberg et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans
Petra Bacher et al.
CELL (2019)
Distinct Antibody Signatures Associated with Different Malaria Transmission Intensities in Zambia and Zimbabwe
Tamaki Kobayashi et al.
MSPHERE (2019)
Safety and Differential Antibody and T-Cell Responses to the Plasmodium falciparum Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and Infants
Said A. Jongo et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2019)
Immunization with merozoite surface protein 2 fused to a Plasmodium-specific carrier protein elicits strain-specific and strain-transcending, opsonizing antibody
Jacqueline S. Eacret et al.
SCIENTIFIC REPORTS (2019)
Vaccination With Sporozoites: Models and Correlates of Protection
Yun Shan Goh et al.
FRONTIERS IN IMMUNOLOGY (2019)
Fungus-Specific CD4 T Cells as Specific Sensors for Identification of Pulmonary Fungal Infections
Alexander Scheffold et al.
MYCOPATHOLOGIA (2018)
Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men
Ally Olotu et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2018)
Antibody Profiling by Proteome Microarray with Multiplex Isotype Detection Reveals Overlap between Human and Aotus nancymaae Controlled Malaria Infections
Omid Taghavian et al.
PROTEOMICS (2018)
The Development of Whole Sporozoite Vaccines for Plasmodium falciparum Malaria
Leslie S. Itsara et al.
FRONTIERS IN IMMUNOLOGY (2018)
Sterile protection against human malaria by chemoattenuated PfSPZ vaccine
Benjamin Mordmueller et al.
NATURE (2017)
Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection
Kirsten E. Lyke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Protection against Plasmodium falciparum malaria by PfSPZ Vaccine
Judith E. Epstein et al.
JCI INSIGHT (2017)
Regulatory T Cell Specificity Directs Tolerance versus Allergy against Aeroantigens in Humans
Petra Bacher et al.
CELL (2016)
Characterization of a novel inhibitory human monoclonal antibody directed against Plasmodium falciparum Apical Membrane Antigen 1
Dominika J. Maskus et al.
SCIENTIFIC REPORTS (2016)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines
Thomas L. Richie et al.
VACCINE (2015)
Antigen-Reactive T Cell Enrichment for Direct, High-Resolution Analysis of the Human Naive and Memory Th Cell Repertoire
Petra Bacher et al.
JOURNAL OF IMMUNOLOGY (2013)
Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria
Stephen L. Hoffman et al.
HUMAN VACCINES (2010)
Natural Immunization Against Malaria: Causal Prophylaxis with Antibiotics
Johannes Friesen et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Microarray background correction: maximum likelihood estimation for the normal-exponential convolution
Jeremy D. Silver et al.
BIOSTATISTICS (2009)
Protection against a Malaria Challenge by Sporozoite Inoculation.
Meta Roestenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Profiling humoral immune responses to P-falciparum infection with protein microarrays
Denise L. Doolan et al.
PROTEOMICS (2008)
A comparison of background correction methods for two-colour microarrays
Matthew E. Ritchie et al.
BIOINFORMATICS (2007)
Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment
E Belnoue et al.
JOURNAL OF IMMUNOLOGY (2004)
Share Paper
